Guide | July 22, 2025
A medical breakthrough in orthopedic treatment: The ROC in Aschheim near Munich relies on an innovative stem cell therapy using the patient’s own blood to treat chronic degenerative conditions such as osteoarthritis and tendon and ligament injuries. The clinic exclusively uses the novel Miracell® SMART M-CELL2 system, which is being applied in a clinical setting for the first time in Germany. This procedure opens up new avenues in regenerative medicine by specifically activating the body’s own healing powers.
Degenerative conditions such as osteoarthritis are chronic and progressive—traditional treatment methods like pain medication, orthotics, physical therapy, or surgery usually offer only short-term relief or are associated with risks and long rehabilitation periods. The ROC in Aschheim takes a different approach: stem cell therapy using the patient’s own blood harnesses the body’s natural potential to regenerate damaged cartilage, bones, tendons, and ligaments in a sustainable way—without any invasive procedures and without side effects.
The ROC in Aschheim is the first clinic in Germany to use the Miracell® SMART M-CELL2 system for the collection and activation of stem cells from the patient’s own blood. This system produces a highly concentrated cell preparation with improved cell viability and quality—both of which are crucial to the success of the treatment.
As part of the treatment, 30 to 60 milliliters of blood are drawn, processed in the Miracell® centrifuge, and stimulated by LED light of various wavelengths. These light pulses increase the cells’ regenerative activity and specifically promote natural wound healing. The final product contains revitalized mesenchymal stem cells (MSCs) and growth-promoting components of blood plasma—a powerful combination for targeted use in treating joint pain.
After preparation, the cell preparation is injected directly into the affected joint, muscle, or tendon. The treatment at the ROC in Aschheim takes only about 30 minutes in total, is performed on an outpatient basis, and is virtually painless. In most cases, no additional pain medication or extended downtime is required.
Many patients report noticeable pain relief, improved mobility, and an overall better quality of life just a few weeks after treatment. Depending on each patient’s individual situation, the therapeutic effects can last for months or even years.
Stem cell therapy using autologous blood at the ROC in Aschheim is used to treat a wide range of conditions, including:
The major advantage: It is a minimally invasive, low-risk method that supports the body's own regenerative processes rather than merely treating symptoms.
In addition to autologous blood, the ROC in Aschheim also uses stem cells derived from adipose tissue or ear cartilage, depending on the medical indication. The choice of cell type is made on a case-by-case basis and is based on the nature of the condition, the treatment goal, and the patient’s physical constitution.
As a result, the ROC offers a patient-centered treatment approach—unique in Germany—for the treatment of degenerative diseases of the musculoskeletal system.
The ROC’s orthopedic department is one of the few institutions in Germany dedicated to the ongoing research, development, and application of modern stem cell technologies. Its goal is to bring about lasting improvements in the treatment of degenerative joint diseases through scientifically sound, personalized cell therapies.
Because stem cell therapy using the patient’s own blood in this form is unique in Germany, many patients are willing to travel a longer distance to receive treatment at the ROC in Aschheim near Munich. Most come from the region around Munich—such asMunich,Augsburg,Ingolstadt, orRosenheim—but many also travel from other parts of Germany or fromabroad. You can find the fastest way to reach the ROC on ourDirections page.
Schedule a consultation now!
ROC Ortho
St.-Emmeram-Str. 5
85609 Aschheim
Phone: 089 46259930
E-mail: praxis@roc-ortho.de